SARA ORNELAS: Open Payments
NPI 1891559910 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$133 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $36 · 2025 $133
Food & beverage: $133
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, CAPLYTA, FANAPT.
Industry payments across NM — which companies pay providers there.
